Biopol Chemicals IPO was launched as a Book Built SME public issue by Biopol Chemicals Limited. The issue consisted entirely of a fresh issue of equity shares, allowing the company to raise funds for its future growth initiatives. Through the public offering, the company intends to strengthen its manufacturing capabilities, support working capital requirements, finance planned capital expenditure, and meet general corporate requirements. After the completion of the IPO process, the company’s equity shares were listed on the NSE SME platform.
Biopol Chemicals Limited is engaged in the production of specialty chemical products that serve a variety of industrial applications. The company develops and manufactures chemical formulations designed to meet the requirements of customers operating across multiple industrial sectors. Its operations focus on delivering consistent product quality, efficient manufacturing processes, and dependable customer service.
The company operates manufacturing facilities equipped with modern production infrastructure and quality control systems. By continuously improving production efficiency, maintaining quality standards, and expanding its product portfolio, Biopol Chemicals Limited aims to strengthen its position in the specialty chemicals industry.
India’s specialty chemicals sector continues to benefit from rising industrial production, increasing domestic consumption, supportive government initiatives, and growing export opportunities. As manufacturers increasingly diversify their supply chains, Indian specialty chemical companies are expected to benefit from favourable long-term industry trends.
Although the IPO has already concluded and the shares are listed, investors should carefully evaluate the company’s financial performance, manufacturing capabilities, industry outlook, valuation, and long-term business strategy before making an investment decision.
Biopol Chemicals IPO Details
| IPO Details | Information |
|---|---|
| IPO Name | Biopol Chemicals IPO |
| Company Name | Biopol Chemicals Limited |
| IPO Type | Book Built Issue |
| IPO Category | SME IPO |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹102 to ₹108 Per Share |
| Issue Size | ₹31.26 Crore |
| Fresh Issue | ₹31.26 Crore |
| Offer for Sale | Nil |
| Fresh Issue Shares | 28,94,400 Equity Shares |
| IPO Open Date | 6 February 2026 |
| IPO Close Date | 10 February 2026 |
| Basis of Allotment | 11 February 2026 |
| Refund Initiation | 12 February 2026 |
| Shares Credited to Demat Account | 12 February 2026 |
| Listing Date | 13 February 2026 |
| Listing Exchange | NSE SME |
| Lot Size | 1,200 Equity Shares |
| Registrar | Bigshare Services Private Limited |
| Book Running Lead Manager | Smart Horizon Capital Advisors Private Limited |
The IPO comprised only a fresh issue of equity shares, with no offer for sale by existing shareholders. The capital raised through the issue is planned to be utilised for strengthening manufacturing operations, funding capital expenditure, meeting working capital requirements, and supporting other business needs.
Biopol Chemicals IPO Dates
The schedule of the Biopol Chemicals IPO is provided below.
| IPO Event | Date |
|---|---|
| IPO Opening Date | 6 February 2026 |
| IPO Closing Date | 10 February 2026 |
| Basis of Allotment | 11 February 2026 |
| Refund Initiation | 12 February 2026 |
| Shares Credited to Demat Account | 12 February 2026 |
| Listing Date | 13 February 2026 |
After the allotment process was completed, successful applicants received the allotted shares in their demat accounts before the company’s equity shares commenced trading on the NSE SME platform.
Biopol Chemicals IPO Reservation
The equity shares available under the IPO were distributed among different investor categories in accordance with the applicable regulatory framework for SME public issues.
| Investor Category | Reservation |
|---|---|
| Qualified Institutional Buyers (QIB) | Not More Than 50% |
| Non-Institutional Investors (NII) | Not Less Than 15% |
| Retail Individual Investors (RII) | Not Less Than 35% |
The final allocation under each category was determined based on the valid bids received during the subscription period.
Biopol Chemicals IPO Lot Size
Investors were required to submit applications in multiples of the prescribed lot size.
| Application | Shares | Amount |
|---|---|---|
| Retail Minimum | 2 Lots (2,400 Shares) | ₹2,59,200 |
| Retail Maximum | 2 Lots (2,400 Shares) | ₹2,59,200 |
| HNI Minimum | 3 Lots (3,600 Shares) | ₹3,88,800 |
The investment amounts shown above are calculated using the upper price band of ₹108 per equity share. Applicants were required to apply in multiples of the specified lot size prescribed for the issue.
About Biopol Chemicals Limited
Biopol Chemicals Limited is an Indian specialty chemicals manufacturing company engaged in developing, producing, and supplying a wide range of chemical products for industrial applications. The company focuses on manufacturing high-quality specialty chemicals that are used by customers operating across multiple industries. By combining technical expertise with modern manufacturing practices, the company aims to deliver products that meet customer requirements while maintaining consistent quality standards.
Since its establishment, the company has continuously expanded its manufacturing capabilities, product portfolio, and customer base. Its operations are supported by modern production facilities, quality assurance systems, and a team of experienced professionals who work towards improving manufacturing efficiency and product performance.
Biopol Chemicals Limited places significant emphasis on research, process improvement, and quality control. The company regularly upgrades its manufacturing processes to improve productivity, maintain product consistency, and comply with applicable industry standards. This approach has helped it establish long-term relationships with customers across various industrial sectors.
With increasing demand for specialty chemicals in domestic and international markets, the company continues to focus on expanding its manufacturing capacity, strengthening customer relationships, and improving operational efficiency to support sustainable business growth.
Business Operations
Biopol Chemicals Limited manufactures and supplies specialty chemical products that cater to the requirements of different industries. The company’s operations cover manufacturing, quality control, product development, and distribution.
Its major business activities include:
- Manufacturing specialty chemicals for industrial applications.
- Producing customised chemical formulations based on customer specifications.
- Supplying specialty chemicals to customers across various industrial sectors.
- Maintaining quality control through laboratory testing and process monitoring.
- Developing new products to address changing market requirements.
- Strengthening manufacturing efficiency through process optimisation.
- Managing procurement, production, packaging, and product dispatch.
- Building long-term relationships with customers through consistent product quality and reliable delivery.
The company continuously works towards improving operational efficiency while expanding its product offerings to meet evolving customer requirements.
Manufacturing Facilities
Biopol Chemicals Limited operates manufacturing facilities equipped with modern production equipment and quality control infrastructure. These facilities support the production of specialty chemicals while ensuring consistency in manufacturing standards and product quality.
The company follows structured manufacturing processes that include raw material procurement, production planning, quality inspection, packaging, storage, and dispatch. Regular monitoring throughout the manufacturing cycle helps maintain product reliability and operational efficiency.
The manufacturing infrastructure also enables the company to increase production capacity, introduce new products, and meet growing customer demand across different industries.
Industry Overview
India has emerged as one of the fastest-growing specialty chemicals markets globally. Rising industrialisation, increasing domestic consumption, expanding export opportunities, and supportive government initiatives have contributed significantly to the sector’s growth.
Specialty chemicals are widely used in industries such as pharmaceuticals, agriculture, paints and coatings, textiles, plastics, construction, automotive, personal care, water treatment, and industrial manufacturing. As these industries continue to expand, the demand for high-quality chemical products is expected to increase.
Global manufacturers are also diversifying their supply chains, creating additional opportunities for Indian chemical companies. Improvements in manufacturing infrastructure, technology adoption, environmental compliance, and research capabilities have further strengthened India’s position in the global specialty chemicals market.
Going forward, increasing investments in manufacturing, higher export demand, and continued industrial development are expected to support long-term growth for companies operating in the specialty chemicals sector.
Business Strategy
Biopol Chemicals Limited aims to strengthen its market position by expanding manufacturing capacity, improving product quality, and increasing its customer base across domestic and international markets.
The company plans to continue investing in manufacturing infrastructure, production technology, and quality assurance systems to improve operational efficiency and product consistency. It also intends to develop new specialty chemical products that address changing customer requirements and emerging industry trends.
Another important area of focus is strengthening customer relationships by providing reliable product quality, timely deliveries, and customised solutions. The company also plans to optimise manufacturing processes to improve productivity while maintaining cost efficiency.
Through continuous investment in technology, manufacturing capabilities, product development, and customer service, Biopol Chemicals Limited seeks to achieve sustainable long-term growth and strengthen its presence in the specialty chemicals industry.
Biopol Chemicals IPO Financial Information
A company’s financial performance plays an important role in evaluating its operational strength, profitability, and long-term sustainability. Investors generally analyse revenue growth, profitability, net worth, borrowings, and key financial ratios before making an investment decision. These indicators provide valuable insights into the company’s financial health and business performance over multiple financial years.
Biopol Chemicals Financial Summary
| Particulars | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue from Operations | ₹118.42 Crore | ₹146.81 Crore | ₹184.63 Crore |
| Total Income | ₹119.05 Crore | ₹147.56 Crore | ₹185.47 Crore |
| EBITDA | ₹15.38 Crore | ₹19.84 Crore | ₹25.72 Crore |
| Profit Before Tax (PBT) | ₹11.96 Crore | ₹15.67 Crore | ₹20.86 Crore |
| Profit After Tax (PAT) | ₹8.91 Crore | ₹11.68 Crore | ₹15.62 Crore |
| Net Worth | ₹32.74 Crore | ₹44.19 Crore | ₹59.83 Crore |
| Total Borrowings | ₹18.56 Crore | ₹20.71 Crore | ₹22.84 Crore |
The company has reported consistent improvement in revenue and earnings during the last three financial years. Growth in operating income has been accompanied by higher profitability and an increase in shareholders’ net worth. The financial performance reflects the company’s continued focus on expanding manufacturing operations, improving production efficiency, and strengthening its position in the specialty chemicals market.
Biopol Chemicals IPO Key Performance Indicators (KPIs)
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 31.47% |
| Return on Capital Employed (ROCE) | 29.84% |
| Return on Net Worth (RONW) | 26.11% |
| EBITDA Margin | 13.87% |
| PAT Margin | 8.42% |
| Debt-to-Equity Ratio | 0.38 |
| Earnings Per Share (EPS) | ₹8.52 |
| Net Asset Value (NAV) Per Share | ₹32.64 |
| Price to Earnings (P/E) | 12.68x |
The company’s profitability ratios indicate efficient utilisation of capital and shareholders’ funds. Stable operating margins, controlled borrowings, and healthy return ratios highlight improving business efficiency. Investors may also consider EPS, NAV, and the price-to-earnings ratio while assessing the company’s valuation relative to its financial performance.
Objects of the Biopol Chemicals IPO
The company proposes to utilise the net proceeds from the fresh issue for the following purposes:
- Funding capital expenditure for business expansion.
- Meeting incremental working capital requirements.
- Investment in plant, machinery, and manufacturing infrastructure.
- Strengthening operational capabilities.
- General corporate purposes.
The planned utilisation of IPO proceeds is expected to support the company’s expansion strategy by increasing production capacity, improving manufacturing efficiency, strengthening working capital, and enhancing its overall operational capabilities. These investments are intended to help the company meet future business requirements while supporting long-term growth.
Biopol Chemicals IPO Listing Performance
The listing performance of an IPO reflects the market’s initial response after the company’s shares begin trading on the stock exchange. While listing gains may indicate positive investor sentiment, long-term investment decisions should be based on the company’s financial performance, business fundamentals, industry outlook, and future growth prospects.
Biopol Chemicals IPO Listing Details
| Particular | Value |
|---|---|
| Listing Exchange | NSE SME |
| Listing Date | 13 February 2026 |
| Issue Price | ₹108 Per Share |
| Listing Price | ₹132.00 Per Share |
| Listing Gain | 22.22% |
| Closing Price on Listing Day | ₹138.60 Per Share |
The shares of Biopol Chemicals Limited commenced trading on the NSE SME platform at a premium over the issue price, reflecting encouraging investor participation during the listing. However, investors should assess the company’s long-term business potential instead of relying solely on listing-day performance.
Biopol Chemicals IPO Subscription Status
The subscription data indicates the level of demand received from various categories of investors during the IPO bidding period. Strong subscription generally reflects investor confidence, although investment decisions should also consider the company’s valuation, financial position, and future growth opportunities.
Biopol Chemicals IPO Subscription
| Investor Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIB) | 19.84 Times |
| Non-Institutional Investors (NII) | 132.57 Times |
| Retail Individual Investors (RII) | 87.43 Times |
| Total Subscription | 72.91 Times |
The IPO attracted strong demand across all investor categories. The Non-Institutional Investor (NII) segment witnessed the highest participation, while both Retail Individual Investors (RIIs) and Qualified Institutional Buyers (QIBs) also subscribed the issue multiple times, indicating broad market interest.
Biopol Chemicals IPO Review
Biopol Chemicals Limited operates in the specialty chemicals industry and manufactures products used across multiple industrial applications. The company focuses on delivering quality chemical products supported by modern manufacturing facilities, process efficiency, and customer-oriented solutions.
The company has gradually expanded its manufacturing capacity and product portfolio while strengthening relationships with customers across different industries. Continuous investment in production infrastructure, quality control, and operational efficiency has supported its business growth over the years.
India’s specialty chemicals sector continues to benefit from increasing industrial production, growing export opportunities, favourable government initiatives, and rising demand from end-user industries. These factors are expected to provide long-term growth opportunities for companies operating in this segment.
However, investors should also evaluate potential risks, including fluctuations in raw material prices, intense competition, environmental and regulatory compliance requirements, customer concentration, and changes in demand from key industries. A comprehensive assessment of the company’s financial performance, valuation, management quality, and business strategy is recommended before making any investment decision.
Biopol Chemicals IPO Strengths
Biopol Chemicals Limited has developed several competitive advantages that support its business operations and future growth.
- Diversified portfolio of specialty chemical products.
- Modern manufacturing infrastructure with quality-focused production processes.
- Experienced management team with industry expertise.
- Long-standing relationships with customers across multiple industries.
- Consistent growth in revenue and profitability.
- Focus on operational efficiency and process improvement.
- Growing opportunities supported by expanding specialty chemicals demand.
- Scalable business model with capacity for future expansion.
Biopol Chemicals IPO Risk Factors
Like any manufacturing business, Biopol Chemicals Limited is exposed to various operational and industry-related risks that investors should consider.
- The business depends on the availability and pricing of raw materials.
- Intense competition may affect pricing and profit margins.
- Changes in environmental regulations could increase compliance costs.
- Demand from end-user industries may fluctuate due to economic conditions.
- Manufacturing operations may be affected by operational disruptions or equipment failures.
- Customer concentration may impact revenue if key clients reduce their orders.
- Expansion plans require effective execution and capital management.
- Any slowdown in the specialty chemicals industry could influence future business performance.
Biopol Chemicals IPO Promoters
Biopol Chemicals Limited is promoted by experienced professionals who have played an important role in establishing and expanding the company’s operations in the specialty chemicals industry. Under their leadership, the company has focused on strengthening its manufacturing capabilities, maintaining product quality, expanding its customer base, and improving operational efficiency. The promoters continue to guide the company’s long-term business strategy while supporting sustainable growth.
Biopol Chemicals IPO Promoters Details
| Promoter | Designation |
|---|---|
| Bharat M. Vaghasiya | Promoter & Managing Director |
| Jignesh B. Vaghasiya | Promoter & Whole-Time Director |
Biopol Chemicals IPO Management Team
Biopol Chemicals Limited is managed by a team of professionals with experience in chemical manufacturing, finance, operations, marketing, and corporate governance. The management team is responsible for overseeing the company’s business activities, implementing growth strategies, maintaining quality standards, and ensuring compliance with applicable regulations.
| Name | Designation |
|---|---|
| Bharat M. Vaghasiya | Managing Director |
| Jignesh B. Vaghasiya | Whole-Time Director |
| Kalpesh K. Vaghasiya | Executive Director |
| Nirav Patel | Chief Financial Officer |
| Priyanka Patel | Company Secretary & Compliance Officer |
| Independent Directors | Independent Directors |
Biopol Chemicals IPO Registrar Details
Bigshare Services Private Limited was appointed as the registrar to the public issue. The registrar handled the IPO application process, prepared the basis of allotment, facilitated the credit of allotted shares to investors’ demat accounts, processed refunds wherever applicable, and addressed investor-related queries after the completion of the issue.
| Particular | Details |
|---|---|
| Registrar Name | Bigshare Services Private Limited |
| Website | www.bigshareonline.com |
| IPO Allotment Status | https://ipo.bigshareonline.com/IPO_Status.html |
| Email ID | [email protected] |
| Contact Number | +91-22-6263 8200 |
Investors may contact the registrar regarding allotment status, refund requests, demat credit, and other IPO-related services.
Biopol Chemicals IPO Lead Manager Details
Smart Horizon Capital Advisors Private Limited acted as the Book Running Lead Manager for the IPO. The lead manager coordinated various activities associated with the public issue, including regulatory compliance, issue management, documentation, and coordination with intermediaries to facilitate the successful completion of the offering.
| Particular | Details |
|---|---|
| Lead Manager | Smart Horizon Capital Advisors Private Limited |
| Website | https://shcapl.com/ |
| Email ID | [email protected] |
| Contact Number | +91-79-4900 7568 |
The lead manager also assisted the company throughout the IPO process by managing issue-related activities and ensuring compliance with the applicable regulatory framework.
Biopol Chemicals Limited Contact Details
The following contact details may be used by investors, shareholders, customers, and other stakeholders for business and investor-related communication.
| Particular | Details |
|---|---|
| Company Name | Biopol Chemicals Limited |
| Registered Office | Survey No. 168, Plot No. 2, Veraval (Shapar), Rajkot, Gujarat – 360024, India |
| Website | www.biopolchemicals.com |
| Email ID | [email protected] |
| Phone Number | +91-2827-252701 |
How to Check Biopol Chemicals IPO Allotment Status
Applicants could check the IPO allotment status once the basis of allotment was finalised through either the registrar’s portal or the NSE IPO platform.
Through Bigshare Services Private Limited
- Visit the official IPO allotment page of Bigshare Services Private Limited.
- Select Biopol Chemicals IPO from the list of available public issues.
- Choose any one of the available search options such as PAN, Application Number, or DP/Client ID.
- Enter the required information.
- Click on the submit button to view the allotment status.
Through NSE
- Visit the official NSE IPO allotment portal.
- Select Biopol Chemicals IPO from the available IPO list.
- Enter your PAN number or application number.
- Complete the verification process if required.
- Click on Search to check your allotment result.
Frequently Asked Questions (FAQs)
What is Biopol Chemicals IPO?
Biopol Chemicals IPO is a Book Built SME public issue consisting entirely of a fresh issue of equity shares.
What was the price band of the Biopol Chemicals IPO?
The IPO was offered at a price band of ₹102 to ₹108 per equity share.
What was the total issue size of the Biopol Chemicals IPO?
The total issue size of the IPO was ₹31.26 crore.
When did the Biopol Chemicals IPO open and close?
The IPO opened on 6 February 2026 and closed on 10 February 2026.
On which stock exchange are Biopol Chemicals shares listed?
The company’s equity shares are listed on the NSE SME platform.
Who was the registrar for the Biopol Chemicals IPO?
Bigshare Services Private Limited was appointed as the registrar to the issue.
Who was the lead manager for the Biopol Chemicals IPO?
Smart Horizon Capital Advisors Private Limited served as the Book Running Lead Manager for the IPO.
What was the minimum lot size for the Biopol Chemicals IPO?
Retail investors were required to apply for a minimum of 2 lots comprising 2,400 equity shares.
What does Biopol Chemicals Limited do?
The company manufactures and supplies specialty chemical products for various industrial applications while focusing on quality, process efficiency, and customer-specific solutions.
What were the objectives of the Biopol Chemicals IPO?
The company plans to utilise the IPO proceeds for capital expenditure, working capital requirements, business expansion, and general corporate purposes.
